WORK Medical Technology Group LTD (WOK) AI Stock Analysis

• Market Cap: $5.08M
• Dividend Yield: N/A
• Average Volume (3M): 33.04M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.74
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 216
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): N/A
• Shares Outstanding: 79,054,535
• 10 Day Avg. Volume: 36,687,585
• 30 Day Avg. Volume: 33,038,725
• PEG Ratio: <0.01
• Price to Book (P/B): 5.03
• Price to Sales (P/S): 5.77
• P/FCF Ratio: -5.78
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $1.00
• Price Target Upside: 2400.00% Upside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 1

• Rating: 37 Underperform
• Price Target: $0.00 ▼(-100.00% Downside)

WORK Medical Technology Group LTD is facing severe financial and operational challenges, as reflected in its poor financial performance and bearish technical indicators. The lack of profitability and absence of shareholder returns further exacerbate the company's valuation concerns. Immediate strategic interventions are necessary to address these issues.

WORK Medical Technology Group LTD Business Overview & Revenue Model

Company Description

WORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People's Republic of China and internationally. The company offers disposable medical devices, such as medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half mask; and visualized prostatic dilatation catheters. It also exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.

How the Company Makes Money

WORK Medical Technology Group LTD generates revenue through a diverse array of channels. The primary source of income is the sale of its medical devices and software solutions to healthcare institutions and professionals. The company also offers subscription-based models for its software products, which provide continuous updates and support, ensuring recurring revenue. Additionally, WOK engages in strategic partnerships with healthcare providers and technology companies to expand its market reach and enhance its product offerings, further contributing to its revenue streams.

WORK Medical Technology Group LTD Financial Statement Overview

Summary

WORK Medical Technology Group LTD faces significant financial challenges, with declining revenues, operational inefficiencies, and high leverage. The company's inability to generate positive cash flow from operations and reliance on external financing pose risks to its financial health. Strategic improvements are necessary to enhance profitability and stabilize cash flows.

Income Statement

The company has experienced a significant decline in revenue over the past few years, with a negative revenue growth rate from 2020 to 2024. Gross profit margin has decreased, and the company is currently operating at a net loss, indicating challenges in maintaining profitability. The negative EBIT and EBITDA margins further highlight operational inefficiencies.

Balance Sheet

The balance sheet shows a high level of debt relative to equity, with a debt-to-equity ratio indicating potential leverage risks. The equity ratio is moderate, suggesting a balanced asset structure. However, the negative return on equity reflects poor profitability, impacting overall financial stability.

Cash Flow

The cash flow statement reveals negative free cash flow growth, indicating difficulties in generating cash from operations. The operating cash flow to net income ratio is negative, suggesting inefficiencies in converting income into cash. The company relies heavily on financing activities to sustain operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	10.74M	11.51M	13.57M	19.71M	45.86M	52.53M
Gross Profit	2.89M	2.87M	4.14M	4.42M	8.64M	10.85M
EBITDA	-4.09M	-1.71M	2.08M	4.72M	11.87M	4.75M
Net Income	-3.71M	-3.49M	112.03K	865.21K	5.96M	1.16M
Balance Sheet
Total Assets	34.71M	36.25M	29.96M	25.54M	30.66M	56.20M
Cash, Cash Equivalents and Short-Term Investments	2.00M	6.56M	1.60M	731.18K	508.71K	200.40K
Total Debt	13.04M	13.47M	9.10M	6.30M	6.60M	4.05M
Total Liabilities	19.00M	20.18M	18.97M	14.35M	19.26M	50.27M
Stockholders Equity	12.95M	13.19M	9.88M	10.00M	10.04M	4.90M
Cash Flow
Free Cash Flow	-13.20M	-11.49M	1.63M	-4.27M	-7.24M	9.65M
Operating Cash Flow	-3.76M	-2.23M	2.21M	-2.26M	-7.18M	27.20M
Investing Cash Flow	318.29K	-9.06M	-583.30K	-1.35M	-60.00K	-16.84M
Financing Cash Flow	2.05M	15.66M	-728.72K	3.57M	7.99M	-10.28M

WORK Medical Technology Group LTD Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WOK, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.54, and below the 200-day MA of 1.08, indicating a bearish trend. The MACD of -0.15 indicates Negative momentum. The RSI at 15.40 is Positive, neither overbought nor oversold. The STOCH value of 6.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for WOK.

WORK Medical Technology Group LTD Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MHUA	60 Neutral	$11.53M	1.07	5.90%	―	-4.99%	-19.11%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
MLSS	46 Neutral	$34.97M	―	-123.50%	―	7.84%	-43.00%
FEMY	45 Neutral	$32.06M	―	-329.45%	―	98.61%	-1.98%
WOK	37 Underperform	$5.08M	―	―	―	―	―